BRPI0819105A2 - composition for the treatment and prevention of eyelid edema - Google Patents

composition for the treatment and prevention of eyelid edema

Info

Publication number: BRPI0819105A2
Authority: BR; Brazil
Prior art keywords: prevention; treatment; composition; eyelid edema; eyelid
Prior art date: 2007-11-08

Application number

BRPI0819105A

Other languages

Portuguese (pt)

Inventor

Minno George

Jeffrey Lane Keith

Barry Abelson Mark

Jonathan Chapin Matthew

Original Assignee

Aciex Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-08

Filing date

2008-11-06

Publication date

2019-09-24

2008-11-06 Application filed by Aciex Therapeutics Inc filed Critical Aciex Therapeutics Inc

2019-09-24 Publication of BRPI0819105A2 publication Critical patent/BRPI0819105A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Inorganic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0819105A 2007-11-08 2008-11-06 composition for the treatment and prevention of eyelid edema BRPI0819105A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US751107P	2007-11-08	2007-11-08
PCT/US2008/012513 WO2009061431A2 (en)	2007-11-08	2008-11-06	Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor

Publications (1)

Publication Number	Publication Date
BRPI0819105A2 true BRPI0819105A2 (en)	2019-09-24

Family

ID=40329067

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0819105A BRPI0819105A2 (en)	2007-11-08	2008-11-06	composition for the treatment and prevention of eyelid edema

Country Status (8)

Country	Link
EP (1)	EP2219630A2 (en)
JP (1)	JP2011503061A (en)
CN (1)	CN101977595A (en)
AU (1)	AU2008325214A1 (en)
BR (1)	BRPI0819105A2 (en)
CA (1)	CA2705050A1 (en)
MX (1)	MX2010005012A (en)
WO (1)	WO2009061431A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120225918A1 (en)	2011-03-03	2012-09-06	Voom, Llc	Compositions and Methods for Non-Surgical Treatment of Ptosis
IN2014CN03950A (en) *	2011-11-01	2015-10-16	Rohto Pharma
EA021247B1 (en) *	2012-03-26	2015-05-29	Ооо "Фармацевтическая Компания "Славянская Аптека"	Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
EA021234B1 (en) *	2012-03-27	2015-05-29	Ооо "Фармацевтическая Компания "Славянская Аптека"	Pharmaceutical composition having vasoconstricting, anticongestant, anti-inflammatory activity (embodiments)
JP6373551B2 (en) *	2012-05-30	2018-08-15	味の素株式会社	Gallotannin-containing composition
AU2013201465B2 (en)	2012-10-24	2016-03-03	Rayner Intraocular Lenses Limited	Stable preservative-free mydriatic and anti-inflammatory solutions for injection
AU2014262960A1 (en) *	2013-05-06	2015-11-26	Allergan, Inc.	Alpha adrenergic agonists for the treatment of tissue trauma
TWI809304B (en)	2014-12-01	2023-07-21	奥默羅斯公司	Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions
US9820954B2 (en)	2015-08-19	2017-11-21	Jenivision Inc.	Quantitative peri-orbital application of ophthalmology drugs
CN115006537A (en)	2016-01-26	2022-09-06	利维申制药有限公司	Compositions and uses of alpha-adrenergic agents
EP3970803A1 (en) *	2020-09-22	2022-03-23	Beiersdorf AG	Cosmetic composition of low osmolality
US20240156786A1 (en) *	2021-03-03	2024-05-16	Voom, Llc	Compositions and methods for treatment of blepharitis
EP4580751A2 (en)	2022-09-29	2025-07-09	Adora Animal Health Corporation	Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions
CN117771183B (en) *	2024-02-27	2024-05-03	深圳大佛药业股份有限公司	Oxymetazoline hydrochloride spray and preparation method thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2618428A (en) *	1947-01-27	1952-11-18	John K M Harrison	Shock resistant container
US5188826A (en) *	1988-02-08	1993-02-23	Insite Vision Incorporated	Topical ophthalmic suspensions
IT1248014B (en) *	1991-06-07	1995-01-05	Inverni Della Beffa Spa	PROTRACTED OPHTHALMIC PREPARATIONS
US5811446A (en) *	1997-04-18	1998-09-22	Cytos Pharmaceuticals Llc	Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US7691829B2 (en) *	1998-03-24	2010-04-06	Petito George D	Composition and method for healing tissues
US6274626B1 (en) *	1998-12-22	2001-08-14	Bausch & Lomb Incorporated	Pheniramine-containing compositions and method for treating allergic responses
JP2001187728A (en) *	1999-12-28	2001-07-10	Lion Corp	Ophthalmic composition
DE10000612A1 (en) *	2000-01-10	2001-07-19	Min Becker	Aqueous active substance preparations, especially eye drops, nasal drops and nasal sprays, contain sodium chloride in place of preservatives
JP2002308775A (en) *	2001-04-06	2002-10-23	Rohto Pharmaceut Co Ltd	External composition
US7288263B2 (en) *	2004-09-13	2007-10-30	Evera Laboratories, Llc	Compositions and methods for treatment of skin discoloration
PL2486942T3 (en) *	2004-11-24	2019-05-31	Meda Pharmaceuticals Inc	Compositions comprising azelastine and methods of use thereof
JP2006232792A (en) *	2005-02-21	2006-09-07	Aile De Beaute:Kk	Skin ageing-improving cosmetic
NZ571690A (en) *	2006-03-31	2011-09-30	Vistakon Pharmaceuticals Llc	Ocular allergy treatments using alcaftadine
CA2650592A1 (en) *	2006-04-26	2007-11-08	Aciex, Inc.	Compositions for the treatment and prevention of eyelid swelling

2008
- 2008-11-06 MX MX2010005012A patent/MX2010005012A/en not_active Application Discontinuation
- 2008-11-06 CA CA2705050A patent/CA2705050A1/en not_active Abandoned
- 2008-11-06 AU AU2008325214A patent/AU2008325214A1/en not_active Abandoned
- 2008-11-06 JP JP2010533093A patent/JP2011503061A/en not_active Withdrawn
- 2008-11-06 CN CN2008801191850A patent/CN101977595A/en active Pending
- 2008-11-06 EP EP08847794A patent/EP2219630A2/en not_active Withdrawn
- 2008-11-06 BR BRPI0819105A patent/BRPI0819105A2/en not_active IP Right Cessation
- 2008-11-06 WO PCT/US2008/012513 patent/WO2009061431A2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2008325214A1 (en)	2009-05-14
WO2009061431A3 (en)	2009-07-23
CA2705050A1 (en)	2009-05-14
WO2009061431A2 (en)	2009-05-14
JP2011503061A (en)	2011-01-27
EP2219630A2 (en)	2010-08-25
CN101977595A (en)	2011-02-16
MX2010005012A (en)	2010-06-23

Publication	Publication Date	Title
BRPI0819105A2 (en)	2019-09-24	composition for the treatment and prevention of eyelid edema
CY2023002I1 (en)	2023-06-09	COMPOSITIONS AND USES FOR THE TREATMENT OF MULTIPLE SCLEROSIS
PT1881823E (en)	2015-03-02	COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISORDERS
BRPI0819241A2 (en)	2015-05-05	Amine-derived compounds for the treatment of ophthalmic disorders and diseases
CR11019A (en)	2009-10-20	3-IMIDAZOLIL-INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
BRPI0919920A2 (en)	2016-02-16	compounds for treating ophthalmic diseases and disorders
BRPI0916862A2 (en)	2016-02-10	compounds useful for the treatment of degenerative and inflammatory diseases
BRPI0921237A2 (en)	2015-09-22	methods and compositions for the treatment of complement-associated disorders
ES2525801T8 (en)	2018-03-20	Compositions and methods for the prevention and treatment of autoimmune diseases
BRPI0716844A2 (en)	2013-10-22	Useful Kinase Inactors for the Treatment of Proliferative Diseases
BRPI0818799A2 (en)	2015-04-22	Compositions for the treatment of parkinson's disease
PL3354276T3 (en)	2020-09-21	COMPOSITIONS FOR THE TREATMENT OF GIASMATIS
BRPI0921321A2 (en)	2018-10-16	methods for the treatment of tumors and tumors
BRPI0915282A2 (en)	2017-02-07	gip-based mixed agonists for the treatment of metabolic disorders and obesity
PT2367561E (en)	2015-10-23	COMPOSITIONS AND METHODS FOR THE TREATMENT OF CELIAC DISEASE
BRPI0917444A2 (en)	2015-12-01	gastric retention pharmaceutical compositions for the treatment and prevention of snc diseases
BRPI0813725A2 (en)	2014-12-30	METHODS AND COMPOSITIONS FOR DISEASE TREATMENT
BRPI1015569A2 (en)	2016-08-16	compounds useful for the treatment of degenerative and inflammatory diseases.
BRPI0816712A2 (en)	2016-11-08	interval therapy for the treatment of tinnitus
BRPI1007929A2 (en)	2015-09-01	"methods and compositions for treating neovascularization".
BRPI0911612A2 (en)	2015-12-15	compositions and methods for the treatment of multiple sclerosis.
PL2205720T3 (en)	2017-06-30	COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
BRPI0917440A2 (en)	2015-12-01	ophthalmic pharmaceutical compositions for the treatment of neoangiogenic eye disorders
BRPI0923567A2 (en)	2016-09-27	new antibacterial agents for the treatment of gram positive infections
BRPI0914454A2 (en)	2015-10-27	"composition for the treatment of epithelial tissue"

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application fees: dismissal - article 86 of industrial property law
2020-01-21	B08K	Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.